Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
Keitaro Domae(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Köichi Toda(The University of Osaka), Satsuki Fukushima(National Cerebral and Cardiovascular Center), Yasushi Sakata(Osaka University), Kyongsun Pak(National Center For Child Health and Development), Hiroko Iseoka, Maki Takeda(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Akima Harada(The University of Osaka), Hiroki Hata(The University of Osaka), Noriyuki Kashiyama(The University of Osaka), Emiko Ito(Chiba University), Shunsuke Saito(The University of Osaka), Yasushi Yoshikawa(The University of Osaka), Tomomi Yamada(Osaka University Hospital)
Cited by 22
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363